Clik here to view.
Boeing Will Make Key 777X Parts in Seattle and 2 Other Dow Movers to Watch
The Boeing Co. (NYSE:BA): Current price $132.96 Once the Washington state legislature passes extending financial incentives for Boeing, and machinists at the company okay a long-term work contract, the...
View ArticleClik here to view.
German Merck Hikes Its 2013 Profit Projection and 2 Other Dow Movers to Watch
Merck & Co. Inc. (NYSE:MRK): Current price $47.79 Merck’s German arm Merck KGaA, which manufactures the cancer drug Erbitux, has raised its profit projection for the year, because cost reductions...
View ArticleClik here to view.
Chevron’s Mississippi Refinery Fire Kills One Employee and 2 Other Dow Movers...
Chevron Corp. (NYSE:CVX): Current price $119.77 Early Friday morning, there was a furnace fire in the “cracking 2 area” at Chevron’s Pascagoula refinery in Mississippi, which resulted in the death of...
View ArticleClik here to view.
3 Healthcare Stock Stories for a Weekend Investment Read
Isis Pharmaceuticals Inc. (NASDAQ:ISIS): Closing price $32.09 Isis announced that it has earned a $5 million milestone payment from GlaxoSmithKline regarding designation of ISIS-GSK as a development...
View ArticleClik here to view.
JPMorgan Exits China Everbright Bank Share Sale and 2 Other Dow Movers to Watch
JPMorgan Chase & Co. (NYSE:JPM): Current price $56.41 The U.S. inquiry into JPMorgan’s hiring practices in China has apparently put an end to the bank’s plans to manage China Everbright Bank Co.’s...
View ArticleClik here to view.
Will Merck’s New Drug Crack the Alzheimer’s Code?
A drug designed by Merck (NYSE:MRK) may be the next big thing in treating patients with Alzheimer’s disease, The Wall Street Journal reports. MK-8931 is the technical name of a drug that is currently...
View ArticleClik here to view.
Merck Wins Over FDA Panel With New Allergy Drug
Merck (NYSE:MRK) received word from the U.S. Food & Drug Adminstration that Grastek, an orally administered grass allergy remedy, was both safe and effective for allergy sufferers, according to a...
View ArticleClik here to view.
Merck Sues Actavis Over Generic NuvaRing
A subsidiary of Actavis, (NYSE:ACT) Warner Chilcott has been accused of trying to market a generic version of the vaginal contraceptive NuvaRing before the expiration of Merck’s (NYSE:MRK) patent on...
View ArticleClik here to view.
Why Merck Is Planning to Change Its Research Strategy
According to The Wall Street Journal, Merck & Co. (NYSE:MRK) is looking to both add and subtract within its drug research wing in hopes of improving its operations. The news outlet reports Merck...
View ArticleClik here to view.
Will These 10 Blue Chips Outperform in 2014?
There are countless strategies to employ when investing in stocks. One of the easiest and most well-known strategies — especially during this time of the year — is called the Dogs of the Dow. The...
View ArticleClik here to view.
Boeing Will Make Key 777X Parts in Seattle and 2 Other Dow Movers to Watch
The Boeing Co. (NYSE:BA): Current price $132.96 Once the Washington state legislature passes extending financial incentives for Boeing, and machinists at the company okay a long-term work contract, the...
View ArticleClik here to view.
German Merck Hikes Its 2013 Profit Projection and 2 Other Dow Movers to Watch
Merck & Co. Inc. (NYSE:MRK): Current price $47.79 Merck’s German arm Merck KGaA, which manufactures the cancer drug Erbitux, has raised its profit projection for the year, because cost reductions...
View ArticleClik here to view.
Chevron’s Mississippi Refinery Fire Kills One Employee and 2 Other Dow Movers...
Chevron Corp. (NYSE:CVX): Current price $119.77 Early Friday morning, there was a furnace fire in the “cracking 2 area” at Chevron’s Pascagoula refinery in Mississippi, which resulted in the death of...
View ArticleClik here to view.
3 Healthcare Stock Stories for a Weekend Investment Read
Isis Pharmaceuticals Inc. (NASDAQ:ISIS): Closing price $32.09 Isis announced that it has earned a $5 million milestone payment from GlaxoSmithKline regarding designation of ISIS-GSK as a development...
View ArticleClik here to view.
JPMorgan Exits China Everbright Bank Share Sale and 2 Other Dow Movers to Watch
JPMorgan Chase & Co. (NYSE:JPM): Current price $56.41 The U.S. inquiry into JPMorgan’s hiring practices in China has apparently put an end to the bank’s plans to manage China Everbright Bank Co.’s...
View ArticleClik here to view.
Will Merck’s New Drug Crack the Alzheimer’s Code?
A drug designed by Merck (NYSE:MRK) may be the next big thing in treating patients with Alzheimer’s disease, The Wall Street Journal reports. MK-8931 is the technical name of a drug that is currently...
View ArticleClik here to view.
Merck Wins Over FDA Panel With New Allergy Drug
Merck (NYSE:MRK) received word from the U.S. Food & Drug Adminstration that Grastek, an orally administered grass allergy remedy, was both safe and effective for allergy sufferers, according to a...
View ArticleClik here to view.
Merck Sues Actavis Over Generic NuvaRing
A subsidiary of Actavis, (NYSE:ACT) Warner Chilcott has been accused of trying to market a generic version of the vaginal contraceptive NuvaRing before the expiration of Merck’s (NYSE:MRK) patent on...
View ArticleClik here to view.
Why Merck Is Planning to Change Its Research Strategy
According to The Wall Street Journal, Merck & Co. (NYSE:MRK) is looking to both add and subtract within its drug research wing in hopes of improving its operations. The news outlet reports Merck...
View ArticleClik here to view.
Will These 10 Blue Chips Outperform in 2014?
There are countless strategies to employ when investing in stocks. One of the easiest and most well-known strategies — especially during this time of the year — is called the Dogs of the Dow. The...
View Article
